Finally, our shRNA data reveal that the anti-proliferative and pro-apoptotic activities of lenalidomide and pomalidomide differ in the relative efficiency of Ikaros and Aiolos degradation in IMiD compound-sensitive MM cells. This evidence concerns the gene IKZF1 and Miyoshi myopathy.